Pharmaceutical

Concentric Analgesics highlights data on vocacapsaicin ...

Vocacapsaicin has demonstrated significant pain relief and early opioid cessatio...

Pharma casts a wide net to hook opportunities in metabo...

The recent success of diabetes and weight loss medications has spurred more inte...

Developing high-potent APIs: The necessary steps to follow

The toxicity of HPAPIs requires careful management and expert CDMOs to assist ac...

Q2 2024 update: electronic medical record (emr) systems...

In the global pharmaceutical industry, there were 2 private equity deals announc...

Cellectis starts alemtuzumab revival with FDA orphan dr...

Alemtuzumab, under the brand name Campath, was pulled from the leukaemia market ...

Sanofi invests $1.4bn in insulin production in Germany

Sanofi has announced a significant investment of €1.3bn ($1.4bn) to expand its i...

FDA expands GSK’s Jemperli approval for endometrial cancer

GSK announced that Jemperli plus chemotherapy has obtained expanded FDA approval...

Merck buys Mirus Bio to boost viral vector bioprocessin...

Merck KGaA has concluded the acquisition of Mirus Bio for €500m ($600m), enhanci...

AbbVie acquires Cerevel Therapeutics for $8.7bn

AbbVie has completed its acquisition of all outstanding shares of Cerevel Therap...

AAIC 2024: Eisai presents positive long-term data with ...

Patients treated with Leqembi over three years have demonstrated a slowing of Al...

Vir Bio trims staff and pipeline to focus on Sanofi-lic...

The company has fired 25% of staff and discontinued pipeline programs to funnel ...

Adaptimmune’s Tecelra gains accelerated approval for sy...

The MAGE-A4-targeted genetically modified T cell therapy is indicated for the tr...

Casgevy: Launch sequence and price analysis of the firs...

In 2023, Casgevy was approved in the US to treat sickle cell disease (SCD), maki...

Novo faces growth challenges despite GLP-1 receptor ago...

The industry is seeking to scale up and satisfy demand for diabetes and obesity ...

Bayer in ecommerce: theme innovation strategy

How many patents did Bayer submit related to ecommerce last quarter, and how man...